Read our latest reports on Latin America here, with analyses and ...
Read our latest reports on Latin America here, with analyses and market statistics that explore the evolving consumer preferences, market environment and inherent growth potential in individual countries, or briefings that assess key strategic themes...
Dietary supplements is expected to see solid current value growth in Brazil in 2023, maintaining the trend seen for many years. During the years of the pandemic, consumers predominantly focused on products that strengthened their immune system. While…
While dietary supplements are expected to register moderate current value growth, constant value growth is expected to be minimal. Dietary supplements are mainly imported and in 2023 costs have been rising for imports, due to a sharp decline in…
Despite ongoing economic instability, consumers remained keen to maintain healthy lifestyles in order to help boost their immune systems. This, alongside the expansion of health food shops, boosted retail volume sales of dietary supplements in 2023.…
Dermatologicals is expected to register moderate constant value and volume growth in 2023. Dermatologicals continues to recover from the removal of pandemic restrictions. With patients again visiting doctors for the last two years, this is a…
Dermatologicals, in some regards, are driven by environmental factors. As such, the emergence of the El Niño Costero climatological event, which increased temperatures in Peru, especially along the coast, ultimately resulted in a higher number of…
While sales of dermatologicals continue to grow in 2023, reflecting a recovery from pandemic-related disruptions. demand is stabilising. Mexicans are no longer facing increased risks to their skin compared to the previous year, and some…
Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…
Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…
Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…
As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…